June 1- 5 - Join Ipsos at ASCO’s annual meeting where more than 32,000 oncology professionals from around the world gather to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.
On May 23, join Ipsos’ Jennifer MacLeod Macey at CAMH’s Difference Makers Symposium for an engaging, inclusive and provocative dialogue that will catalyze individual and collective action for mental health moving forward.
Ipsos Healthcare has announced the expansion of its syndicated Pan-Cancer Testing Monitor (PCTM) to the Australian market. The PCTM, which has been running in the US since 2016, measures and tracks the usage of pan-cancer tests, which are designed to test for a wide range of cancer types to help doctors make more informed treatment decisions.
New global poll finds three concerns top the world’s worry list: financial/political corruption (35%), unemployment (34%) and poverty/social inequality (34%).
Ipsos Healthcare, the global healthcare business of Ipsos, has announced the launch of its syndicated Multiple Sclerosis (MS) Patient Community Panel. This latest offer is part of the Ipsos Healthcare Global Patient Centre of Excellence, launched in 2018.
